Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Cash from Operations (2020 - 2025)

BioAtla's Cash from Operations history spans 6 years, with the latest figure at 7915000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 52.84% year-over-year to 7915000.0; the TTM value through Dec 2025 reached 48204000.0, up 32.99%, while the annual FY2025 figure was 48204000.0, 32.99% up from the prior year.
  • Cash from Operations reached 7915000.0 in Q4 2025 per BCAB's latest filing, up from 9881000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 5132000.0 in Q3 2024 to a low of 30828000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 18839450.0, with a median of 18057000.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: plummeted 343.81% in 2021, then soared 81.23% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 20949000.0 in 2021, then fell by 16.22% to 24347000.0 in 2022, then fell by 22.9% to 29922000.0 in 2023, then skyrocketed by 43.91% to 16783000.0 in 2024, then soared by 52.84% to 7915000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Cash from Operations are 7915000.0 (Q4 2025), 9881000.0 (Q3 2025), and 14120000.0 (Q2 2025).